Centessa Pharmaceuticals plc ADR (NASDAQ:CNTA) currently has a daily average trading volume of 710.22K but it saw 839258 shares traded in last market. With a market cap of 2.09B USD, the company’s current market price of $15.91 came falling about -2.15 while comparing to the previous closing price of $16.26. In past 52 weeks, the stock remained buoying in the range of price level as high as $19.09 and as low as $7.75.
Taking a look at 20-day trading activity of Centessa Pharmaceuticals plc ADR (CNTA) gives us an average price of $17.03, while its current price level is -16.66% below from 52-week high level whereas it is 105.29% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $16.84 while that of 200 days or SMA-200 reads an average of $13.68. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.93% during that period while stretching the period over a month that decreases to 7.39%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.88 which implies that the stock is in neutral territory.
Morgan Stanley upgraded its recommendation for the stock as a “Overweight” from “Equal-Weight” on September 20, 2024 while assigning a price target range of $11-$26. B. Riley Securities also issued its recommendations for the stock as it initiated the price target for the stock is $33.
Over the week, CNTA’s stock price is moving -7.82% down while it is 4.95% when we observe its performance for the past one month. Year-to-date it is -5.01% down and over the past year, the stock is showing an upside performance of 46.91%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.35 while estimate for next year EPS is -1.43.
Currently, Centessa Pharmaceuticals plc ADR’s total number of outstanding shares is 131.66M with 1.29% of that held by the insiders while 97.10% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -27.78% and return on equity (ROE) at -42.73%. Stock’s beta reads 1.53. Stock has a price to book (P/B) ratio of 4.20 while price to sale or P/S ratio amounts to 303.14. Its return on asset (ROA) is -32.83% on average.
